Health status in inflammatory bowel disease. Biological and behavioral considerations

Gastroenterology

Volumn 99, Issue 1, 1990, Pages 90-96

  Garrett, John W ^a   Drossman, Douglas A ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLASSIFICATION; CLINICAL ARTICLE; CROHN DISEASE; ENTERITIS; HEALTH STATUS; HUMAN; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; SOCIAL PSYCHOLOGY; STANDARDIZATION; ULCERATIVE COLITIS;

ADULT; CASE REPORT; CROHN DISEASE; FEMALE; HEALTH STATUS; HUMAN; INFLAMMATORY BOWEL DISEASES; MENTAL HEALTH; PHYSICAL EXAMINATION; QUALITY OF LIFE; SENSITIVITY AND SPECIFICITY;

EID: 0025293522     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/0016-5085(90)91234-W     Document Type: Article

References (59)

1. IOIBD report No 1: observer variation in calculating indices of severity and activity in Crohn's disease
2. The social toll of Crohn's disease
3. Reliability and validity assessment
4. Illness and disease
5. Zur rontgendiagnostic der colitis ulcerosa
6. Cortisone in ulcerative colitis, preliminary report on a therapeutic trial
7. Clinical activity assessment in inflammatory bowel disease
8. Measuring and quantifying the status of patients with inflammatory bowel disease
9. Medical management of acute colitis
10. Short-term course and prognosis of Crohn's disease
11. Controlled trial of azathioprine in Crohn's disease
12. The disease activity of ulcerative colitis and Crohn's disease
13. Development of a Crohn's disease activity index, National Cooperative Crohn's disease study
14. A simple index of Crohn's disease activity
15. The O.M.G.E. multinational inflammatory bowel disease survey 1976–1982: a further report on 2,657 cases
16. A simple clinical index of Crohn's disease activity—the Cape Town Index
17. An index of inflammatory activity in patients with Crohn's disease
18. Development of a Crohn's disease index for survey research
19. Laboratory assessment of inflammatory bowel disease
20. Quantification of disease activity in patients with ulcerative colitis
21. Assessment of appropriate laboratory measures to supplement the Crohn's disease activity index
22. Predictors of acute relapse of Crohn's disease: a laboratory and clinical study
23. A laboratory index for predicting relapse in asymptomatic patients with Crohn's disease
24. Assessment of appropriate laboratory measurements to reflect the degree of activity of ulcerative colitis
25. Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis
26. Determining disease activity in inflammatory bowel disease
27. Erythrocytic sedimentation rate as a measure of clinical activity in inflammatory bowel disease
28. Intestinal protein loss in Crohn's disease
29. Fecal alpha-1-antitrypsin measurement: An indicator of Crohn's disease activity
30. Alpha-1-antitrypsin, a reliable endogenous marker for intestinal protein loss and its application in patients with Crohn's disease
31. Quantitative fecal indium 111-labeled leukocyte excretion in the assessment of disease in Crohn's disease
32. Indium 111-labeled autologous leukocyte imaging and fecal excretion
33. 111-In-leukocytes in Crohn's disease
34. Predicting relapses of Crohn's disease, clouds in the crystal ball
35. Advances in the assessment of disease activity in inflammatory bowel disease
36. Methodological considerations in the selection of health status assessment procedures
37. Choosing measures of health status for individuals in general populations
38. Scientific and clinical problems in indexes of functional disability
39. Validity of a quality of well being scale as an outcome measure in chronic obstructive pulmonary disease
40. Measuring QOL of cancer patients
41. The McMaster Health Index Questionnaire as a measure of quality of life for patients with rheumatoid disease
42. A study of patients on chronic dialysis
43. Sociomedical approaches to disease and treatment outcomes in cardiovascular care
44. Measuring QOL: risks and benefits
45. Health related quality of life in inflammatory bowel disease: functional status and patient worries and concerns
46. Psychosocial influences on mortality after myocardial infarction
47. The assessment of quality of life in inflammatory bowel disease
48. The course and prognosis of Crohn's disease
49. Early and late results of surgical treatment for Crohn's disease
50. Sequelae of colectomy and ileostomy. Comparison between Crohn's colitis and ulcerative colitis
51. Quality of life after surgery for Crohn's disease: a psychological survey
52. Life prospects and quality of life in patients with Crohn's disease
53. The quality of life in Crohn's disease
54. The sickness impact profile: development and final revision of a health status measure
55. Clinical and psychosocial features of UC and CD: a study of the NFIC membership (abstr)
56. Psychosocial and disease predictors of utilization in IBD (abstr)
57. Quality of life in patients with inflammatory bowel disease
58. Do IBD ostomates do better? A study of symptoms and health related quality of life (abstr)
59. The physician and the patient: review of the psychosocial gastrointestinal literature with an integrated approach to the patient